Real-World Study Shows Dupixent Improves AD Symptoms in Children Under 12 YearsOctober 11th 2022
A real-world study of children with moderate-to-severe atopic dermatitis (AD) in China found Dupixent can reduce symptoms and improve pruritus. Traditional therapies had little effect, according to the researchers.
Patients With Moderate-to-Severe Atopic Dermatitis Experience Impaired QOL, Feel Disease BurdenSeptember 21st 2022
A national study in Germany identified the baseline characteristics of patients with moderate-to-severe atopic dermatitis (AD) to understand how they are usually treated with Dupixent in the real world.